• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过大型队列研究估算新发单基因神经发育障碍的患病率。

Estimating the Prevalence of De Novo Monogenic Neurodevelopmental Disorders from Large Cohort Studies.

作者信息

Gillentine Madelyn A, Wang Tianyun, Eichler Evan E

机构信息

Department of Laboratories, Seattle Children's Hospital, Seattle, WA 98105, USA.

Department of Medical Genetics, Center for Medical Genetics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.

出版信息

Biomedicines. 2022 Nov 9;10(11):2865. doi: 10.3390/biomedicines10112865.

DOI:10.3390/biomedicines10112865
PMID:36359385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9687899/
Abstract

Rare diseases impact up to 400 million individuals globally. Of the thousands of known rare diseases, many are rare neurodevelopmental disorders (RNDDs) impacting children. RNDDs have proven to be difficult to assess epidemiologically for several reasons. The rarity of them makes it difficult to observe them in the population, there is clinical overlap among many disorders, making it difficult to assess the prevalence without genetic testing, and data have yet to be available to have accurate counts of cases. Here, we utilized large sequencing cohorts of individuals with rare, de novo monogenic disorders to estimate the prevalence of variation in over 11,000 genes among cohorts with developmental delay, autism spectrum disorder, and/or epilepsy. We found that the prevalence of many RNDDs is positively correlated to the previously estimated incidence. We identified the most often mutated genes among neurodevelopmental disorders broadly, as well as developmental delay and autism spectrum disorder independently. Finally, we assessed if social media group member numbers may be a valuable way to estimate prevalence. These data are critical for individuals and families impacted by these RNDDs, clinicians and geneticists in their understanding of how common diseases are, and for researchers to potentially prioritize research into particular genes or gene sets.

摘要

罕见病影响着全球多达4亿人。在数千种已知的罕见病中,许多是影响儿童的罕见神经发育障碍(RNDDs)。由于多种原因,RNDDs在流行病学评估方面已被证明具有难度。其罕见性使得在人群中观察它们变得困难,许多病症之间存在临床重叠,这使得在没有基因检测的情况下难以评估患病率,而且目前尚无数据可进行准确的病例计数。在此,我们利用患有罕见的、新发单基因疾病的个体的大型测序队列,来估计发育迟缓、自闭症谱系障碍和/或癫痫队列中超过11000个基因的变异患病率。我们发现,许多RNDDs的患病率与先前估计的发病率呈正相关。我们广泛地确定了神经发育障碍中最常发生突变的基因,以及发育迟缓与自闭症谱系障碍各自最常发生突变的基因。最后,我们评估了社交媒体群组的成员数量是否可能是估计患病率的一种有价值的方法。这些数据对于受这些RNDDs影响的个人和家庭、临床医生和遗传学家了解疾病的常见程度至关重要,对于研究人员潜在地优先开展对特定基因或基因集的研究也至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/b533265a981c/biomedicines-10-02865-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/e3843a0ddd9b/biomedicines-10-02865-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/02bcd5a96729/biomedicines-10-02865-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/35c04e642fe3/biomedicines-10-02865-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/b533265a981c/biomedicines-10-02865-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/e3843a0ddd9b/biomedicines-10-02865-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/02bcd5a96729/biomedicines-10-02865-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/35c04e642fe3/biomedicines-10-02865-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0847/9687899/b533265a981c/biomedicines-10-02865-g004.jpg

相似文献

1
Estimating the Prevalence of De Novo Monogenic Neurodevelopmental Disorders from Large Cohort Studies.通过大型队列研究估算新发单基因神经发育障碍的患病率。
Biomedicines. 2022 Nov 9;10(11):2865. doi: 10.3390/biomedicines10112865.
2
A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants.新发单基因神经发育障碍疾病的 de novo 变异发生率目录。
Brain. 2020 Apr 1;143(4):1099-1105. doi: 10.1093/brain/awaa051.
3
Parent-reported outcome measures evaluating communication in individuals with rare neurodevelopmental disorders: A systematic review.家长报告的结局评估工具在评估罕见神经发育障碍个体的沟通能力中的应用:系统综述。
Int J Lang Commun Disord. 2024 Nov-Dec;59(6):2528-2553. doi: 10.1111/1460-6984.13100. Epub 2024 Aug 14.
4
Common genetic variants contribute to risk of rare severe neurodevelopmental disorders.常见遗传变异与罕见严重神经发育障碍风险相关。
Nature. 2018 Oct;562(7726):268-271. doi: 10.1038/s41586-018-0566-4. Epub 2018 Sep 26.
5
The genetics of autism.自闭症的遗传学
Pediatrics. 2004 May;113(5):e472-86. doi: 10.1542/peds.113.5.e472.
6
Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.通过使用群体参考样本优化新生蛋白质截短变异体在神经发育障碍中的作用。
Nat Genet. 2017 Apr;49(4):504-510. doi: 10.1038/ng.3789. Epub 2017 Feb 13.
7
Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.通过对单核苷酸变异和拷贝数变异的统一分析,大规模发现新的神经发育障碍相关基因。
Genome Med. 2022 Apr 26;14(1):40. doi: 10.1186/s13073-022-01042-w.
8
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder.自闭症谱系障碍中罕见的潜在致病性变异的流行率和表型影响。
Mol Autism. 2021 Oct 6;12(1):65. doi: 10.1186/s13229-021-00465-3.
9
De novo variants in neurodevelopmental disorders-experiences from a tertiary care center.神经发育障碍中的新生变异——来自三级医疗中心的经验
Clin Genet. 2021 Jul;100(1):14-28. doi: 10.1111/cge.13946. Epub 2021 Mar 1.
10
Genotype-Phenotype Correlations in Relation to Newly Emerging Monogenic Forms of Autism Spectrum Disorder and Associated Neurodevelopmental Disorders: The Importance of Phenotype Reevaluation after Pangenomic Results.与自闭症谱系障碍及相关神经发育障碍新出现的单基因形式相关的基因型-表型相关性:泛基因组结果后表型重新评估的重要性。
J Clin Med. 2021 Oct 29;10(21):5060. doi: 10.3390/jcm10215060.

引用本文的文献

1
A research roadmap for SCN8A-related disorders: addressing knowledge gaps and aligning research priorities across stakeholders.一份关于与SCN8A相关疾病的研究路线图:填补知识空白并协调各利益相关方的研究重点。
Orphanet J Rare Dis. 2025 Aug 19;20(1):444. doi: 10.1186/s13023-025-03672-w.
2
OCNDS core features are conserved across variants, with loop-region mutations driving greater symptom burden.OCNDS的核心特征在不同变体中是保守的,环区突变导致更重的症状负担。
Front Hum Neurosci. 2025 Jul 3;19:1589897. doi: 10.3389/fnhum.2025.1589897. eCollection 2025.
3
Artificial intelligence-driven genotype-epigenotype-phenotype approaches to resolve challenges in syndrome diagnostics.

本文引用的文献

1
Integrated gene analyses of de novo variants from 46,612 trios with autism and developmental disorders.46612 个自闭症和发育障碍三联体的新生变异的综合基因分析。
Proc Natl Acad Sci U S A. 2022 Nov 15;119(46):e2203491119. doi: 10.1073/pnas.2203491119. Epub 2022 Nov 9.
2
Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.通过对单核苷酸变异和拷贝数变异的统一分析,大规模发现新的神经发育障碍相关基因。
Genome Med. 2022 Apr 26;14(1):40. doi: 10.1186/s13073-022-01042-w.
3
Facebook Support Groups for Pediatric Rare Diseases: Cross-Sectional Study to Investigate Opportunities, Limitations, and Privacy Concerns.
人工智能驱动的基因型-表观基因型-表型方法用于解决综合征诊断中的挑战。
EBioMedicine. 2025 May;115:105677. doi: 10.1016/j.ebiom.2025.105677. Epub 2025 Apr 24.
4
DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.男性与DDX3X相关的神经发育障碍——19例男性新病例队列及文献综述
Eur J Hum Genet. 2025 Mar 31. doi: 10.1038/s41431-025-01832-x.
5
Neurobiological Relationships Between Neurodevelopmental Disorders and Mood Disorders.神经发育障碍与情绪障碍之间的神经生物学关系。
Brain Sci. 2025 Mar 14;15(3):307. doi: 10.3390/brainsci15030307.
6
The skeletal abnormalities and their clinical challenges in -associated syndrome.相关综合征中的骨骼异常及其临床挑战。
JBMR Plus. 2025 Feb 5;9(4):ziaf023. doi: 10.1093/jbmrpl/ziaf023. eCollection 2025 Apr.
7
Clonazepam repurposing in patients through conventional RCT and N-of-1 trials: an experimental strategy for orphan disease development.通过传统随机对照试验和单病例试验对患者进行氯硝西泮的重新利用:罕见病开发的一种实验策略。
J Med Genet. 2025 Feb 26;62(3):210-218. doi: 10.1136/jmg-2024-109951.
8
-related disorder in 87 adults: Natural history and self-sustainability.87名成年人的相关疾病:自然病史与自我维持能力
Genet Med Open. 2024 Jul 23;2:101873. doi: 10.1016/j.gimo.2024.101873. eCollection 2024.
9
Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan-McDermid Syndrome.患有或未患有费兰-麦克德米德综合征儿童粪便的宏分类学和免疫学分析。
Microorganisms. 2024 Oct 2;12(10):2006. doi: 10.3390/microorganisms12102006.
10
The missing link: ARID1B non-truncating variants causing Coffin-Siris syndrome due to protein aggregation.缺失的环节:导致 Coffin-Siris 综合征的 ARID1B 非截断变异体,原因是蛋白质聚集。
Hum Genet. 2024 Aug;143(8):965-978. doi: 10.1007/s00439-024-02688-9. Epub 2024 Jul 19.
儿科罕见病的脸书支持小组:一项横断面研究,旨在调查其机遇、局限性及隐私问题
JMIR Pediatr Parent. 2022 Jan 6;5(1):e31411. doi: 10.2196/31411.
4
Genotype-Phenotype Correlations in 208 Individuals with Coffin-Siris Syndrome.208 例 Coffin-Siris 综合征个体的基因型-表型相关性。
Genes (Basel). 2021 Jun 19;12(6):937. doi: 10.3390/genes12060937.
5
Assessing rare diseases prevalence using literature quantification.利用文献计量学评估罕见病的患病率。
Orphanet J Rare Dis. 2021 Mar 20;16(1):139. doi: 10.1186/s13023-020-01639-7.
6
Evidence for 28 genetic disorders discovered by combining healthcare and research data.通过整合医疗保健和研究数据发现了 28 种遗传疾病的证据。
Nature. 2020 Oct;586(7831):757-762. doi: 10.1038/s41586-020-2832-5. Epub 2020 Oct 14.
7
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.大规模靶向测序鉴定神经发育障碍的风险基因。
Nat Commun. 2020 Oct 1;11(1):4932. doi: 10.1038/s41467-020-18723-y.
8
DYNC1H1-related disorders: A description of four new unrelated patients and a comprehensive review of previously reported variants.DYNC1H1 相关疾病:四位新的无相关患者的描述及对先前报道变异的全面综述
Am J Med Genet A. 2020 Sep;182(9):2049-2057. doi: 10.1002/ajmg.a.61729. Epub 2020 Jul 13.
9
Prevalence of Children Aged 3-17 Years With Developmental Disabilities, by Urbanicity: United States, 2015-2018.3-17 岁残疾儿童流行率,按城市划分:美国,2015-2018 年。
Natl Health Stat Report. 2020 Feb(139):1-7.
10
A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants.新发单基因神经发育障碍疾病的 de novo 变异发生率目录。
Brain. 2020 Apr 1;143(4):1099-1105. doi: 10.1093/brain/awaa051.